2023 annual financial data
iBio 2023 Operating margin
Direct answer
Operating margin was -58,622%.
Operating income was -29,311,000 USD and net income was -29,311,000 USD.
Operating cash flow was -30,436,000 USD.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,000 USD
- Operating income
- -29,311,000 USD
- Net income
- -29,311,000 USD
- Operating cash flow
- -30,436,000 USD